'Well, It's the Risk of the Unknown… Right?': A Qualitative Study of Perceived Risks and Benefits of HIV Cure Research in the United States
Karine Dubé(University of North Carolina at Chapel Hill), Sandra B. Greene(University of North Carolina at Chapel Hill), Jeff Taylor(University of North Carolina at Chapel Hill), Lynda Dee(AIDS United), Stuart Rennie(University of North Carolina at Chapel Hill), Loreen Willenberg, Joseph D. Tucker(University of North Carolina at Chapel Hill), Laurie Sylla(Ministerio de Defensa), David Evans(Advisory Board Company (United States)), Asheley Cockrell Skinner(University of North Carolina at Chapel Hill), Burton Alasdair, Bryan J. Weiner(University of Washington)
Cited by 66
Related Papers
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
|The Lancet HIV|2019|206
Team Structure and Culture Are Associated With Lower Burnout in Primary Care
|The Journal of the American Board of Family Medicine|2014|202
How does the timing of antiretroviral therapy initiation in acute infection affect HIV reservoirs?
|Current Opinion in HIV and AIDS|2014|116